CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
0.94
0%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 15:30

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.08
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02141 %
Charges from full value of position ($-4.07)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02141%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.000812 %
Charges from full value of position ($-0.15)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000812%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.5
Currency EUR
Margin 5.00%
Stock exchange France
Commission on trade 0%

Key Stats
Prev. Close 0.94
Open 0.94
1-Year Change -68.14%
Day's Range 0.9 - 0.95
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 23, 2024 0.94 0.09 10.59% 0.85 1.00 0.85
Jul 22, 2024 0.85 0.08 10.39% 0.77 1.02 0.77
Jul 19, 2024 0.76 0.01 1.33% 0.75 0.78 0.75
Jul 18, 2024 0.76 0.02 2.70% 0.74 0.76 0.74
Jul 17, 2024 0.76 0.01 1.33% 0.75 0.76 0.75
Jul 16, 2024 0.75 0.00 0.00% 0.75 0.76 0.75
Jul 15, 2024 0.75 0.00 0.00% 0.75 0.75 0.75
Jul 12, 2024 0.74 0.00 0.00% 0.74 0.75 0.73
Jul 11, 2024 0.74 0.02 2.78% 0.72 0.74 0.72
Jul 10, 2024 0.74 0.00 0.00% 0.74 0.74 0.73
Jul 9, 2024 0.74 -0.01 -1.33% 0.75 0.75 0.72
Jul 8, 2024 0.76 0.00 0.00% 0.76 0.76 0.75
Jul 5, 2024 0.75 -0.05 -6.25% 0.80 0.80 0.74
Jul 4, 2024 0.78 0.01 1.30% 0.77 0.79 0.76
Jul 3, 2024 0.77 0.00 0.00% 0.77 0.77 0.75
Jul 2, 2024 0.76 -0.01 -1.30% 0.77 0.79 0.75
Jul 1, 2024 0.76 -0.02 -2.56% 0.78 0.84 0.74
Jun 28, 2024 0.77 -0.07 -8.33% 0.84 0.84 0.76
Jun 27, 2024 0.86 -0.03 -3.37% 0.89 0.91 0.85
Jun 26, 2024 0.89 0.00 0.00% 0.89 0.90 0.88

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

DBV Technologies Company profile

About DBV Technologies SA

DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, DBV Technologies SA revenues decreased 49% to $5.7M. Net loss applicable to common stockholders decreased 39% to $98.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Research and Development decrease of 31% to $70.1M (expense), Restructuring decrease from $23M (expense) to $920K (income).

Industry: Proprietary & Advanced Pharmaceuticals

177-181 avenue Pierre Brossolette
MONTROUGE
ILE-DE-FRANCE 92120
FR

People also watch

ETH/USD

3,461.40 Price
-0.620% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Gold

2,418.77 Price
+0.340% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0111%
Overnight fee time 21:00 (UTC)
Spread 0.30

US100

19,458.70 Price
-1.500% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

66,487.30 Price
+0.890% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading